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Monocyte chemoattractant protein-i mediates monocyte/macrophage
influx in anti-thymocyte antibody-induced glomerulonephritis. Chemo-
kines are a family of chemotactic cytokines whose participation in
inflammation in vivo remains to be established. To study the role of
monocyte-chemoattractant-protein-1 (MCP-l) on the glomerular accumu-
lation of leukocytes, rats received a neutralizing anti-MCP-1 antiserum
following the induction of an glomerulonephritis by an anti-thymocyte
antibody (ATS). The infiltration of monocytes/macrophages (M/M) and
granulocytes was analyzed by immunohistology. When studied by North-
ern blotting, glomerular mRNA levels of MCP-i, and interleukin 1j3
(IL-113) increased at three hours and 24 hours following the induction of
the injury. The glomerular mRNA expression of intercellular adhesion
molecule-i (ICAM-1) only increased marginally, whereas the expression
of the chemokine RANTES was not enhanced. In animals that received
anti-MCP-l antibody glomerular MCP-1 mRNA expression increased.
However, the chemoattractant activity for monocytes released into super-
natants of isolated glomeruli was reduced. The anti-MCP-i antibody did
not affect glomerular IL-113, ICAM-1 or RANTES mRNA levels. The
induction of glomerulonephritis was associated with an increased glomer-
ular recruitment of polymorphonuclear granulocytes (PMN5) at three
hours and M/M at 24 hours, when compared with controls. The anti-
MCP-1 antiserum significantly reduced the glomerular M/M infiltration at
24 hours by 40%, but was without effect on glomerular PMN recruitment
or growth of the resident glomerular cells. These studies demonstrate that
MCP-i is an important mediator for monocyte recruitment in this model
of glomerulonephritis. The reduction of M/M infiltration might affect this
glomerular injury.
Infiltration of leukocytes into the glomerulus and the tubuloin-
terstitium is a characteristic feature of many forms of glomerulone-
phritis [1]. Macrophage infiltration is associated with proteinuria and
declining renal function, in both humans and experimental ani-
mals [21. The process of inflammatory cell migration into injured
tissue following firm adhesion to vascular endothelial cells, is
regulated by chemoattractants that are formed at the site of tissue
injury [3]. Among the various groups of chemoattractants, die-
mokines—a group of small chemotactic cytokines—are potent
mediators of leukocyte trafficking in vitro and might play a major
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role in the inflammatory process in vivo [I. Chemokines have
similar molecular characteristics and are divided into two large
groups according to whether the two first cystein residues in the
amino acid sequence, beginning from the N terminal, are directly
adjacent (-C-C- group) or whether they are separated by another
amino acid (-C-X-C- group) [5]. The chemokines are quite
specific chemoattractants for diverse leukocytes. In vitro the -C-C-
group is very selective for monocytes and lymphocytes, whereas
the -C-X-C- group primarily affects PMNs [4—6]. In a series of
recent experimental and clinical studies evidence emerged, that
chemokines are involved in the leukocyte recruitment in many
organs and diverse diseases, including inflammatory injury, met-
abolic diseases, and tumors [7].
In the rat model of anti-thymocyte antibody-induced glomeru-
lonephritis we have recently described increased mRNA and
protein expression of MCP-1 [8] a chemokine of the -C-C- group
that has chemoattractant activity for monocytes. In these experi-
ments, the infiltration of monocytes was strongly correlated with
the glomerular expression of MCP-1. Consecutive studies by other
investigators in animals and humans demonstrated increased
expression of MCP-1 in glomeruli or tubules in association with
the appearance of monocytes in glomeruli or the tubulo-intersti-
tium of kidneys with immune- and non-immune mediated renal
disease [9—12]. These data strongly support the view, that MCP-1
could be involved in the recruitment of monocytes in glomerulo-
nephritis. However, the direct evidence for a role of MCP-1 in
anti-thymocyte antibody-induced glomerulonephritis is still miss-
ing.
To test if blocking the activity of MCP-1 would affect the
accumulation of monocytes into injured glomeruli, a neutralizing
antibody to MCP-1 was used in rats with anti-thymocyte antibody-
induced injury. Infusion of anti-rat MCP-1 antibody caused a
decrease in the chemoattractant activity in glomeruli together
with a significant reduction of monocytes in glomeruli. These data
support the theory that MCP-1 is an important regulator of
monocyte chemoattraction in glomerular immune injury.
Methods
Anti-MCP-1 antibody
Recombinant rat MCP-1 was prepared using reagents pur-
chased as a kit according to manufacturer's instructions (Pichia
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pastoris expression system; In Vitrogen). A modified and short-
ened rat eDNA [13] was prepared by PCR including EcoRI sites
at both 5' and 3' ends and ligated into the EcoRI sites of pPIC9.
The plasmid was transfected into pichia pastoris using PEG and
CaCI2. Selection was carried out in minimal medium without
histidine. Positive clones were grown in the presence of methanol
to induce protein synthesis and secretion. Recombinant yeast
medium was concentrated by loading on a reversed-phase matrix
C8 cartridge (Ailtech Maxi Clean), eluted with 70% acetonnitrile!
0.1% trifluoroacetic acid and lyophilized. Further purification was
carried out by HPLC cation exchange and reversed phase chro-
matography. The resulting purified protein was analyzed by amino
acid microsequencing and was shown to contain the predicted
N-terminal amino acid sequence. The antiserum was induced in
rabbits by the repetitive injection of rabbits with rat MCP-i in
complete and incomplete Freund's adjuvant.
The neutralizing activity of the antiserum was tested in a
chemotactic assay (see below) and the specificity was evaluated by
Western blotting (see below).
Induct ion of glomerulonephritis
Immune mediated mesangial cell injury was induced in male
Wistar rats (180 to 200 g) by the i.v. injection of 0.5 ml/100 g body
weight of an anti-rat thymocyte antiserum (ATS). ATS was
induced in rabbits by repeated immunization with thymocytes
from Lewis rats as described elsewhere [14]. Details of the
characterization of the antiserum was described earlier [14].
Three groups of animals were studied.
Nephritis (N = 12). Animals received 0.5 ml!100 g body wt ATS
i.v. Immediately following the antibody, the rats were injected
with 0.5 ml/100 g body wt of nonimmune rabbit serum.
Nephritis plus anti-MCP-1 antiserum (N = 12. Nephritis was
induced as described above. Following ATS animals received 0.5
ml/100 g body wt of a rabbit anti-rat MCP-1 antiserum.
Controls (N = 6). Rats were injected twice with 0.5 ml!100 g
body wt i.v. of non immune rabbit serum, which was given in
sequential injections.
The study was carried out in two complete sets of experiments
(N = 3 animals, each group and time point). To evaluate
glomerular expression and formation of chemokines and to assess
morphologic changes, kidneys of nephritic animals were removed
three hours and 24 hours following the injection of the antibodies.
Isolation of glomeruli and total RNA for Northern blot
hybridization and chemotactic assay
Glomeruli were isolated by a fractional sieving technique as
described earlier [15]. The yield and purity of glomeruli at each
time point were comparable (purity greater than 90%). Cellular
RNA from glomeruli was isolated by the guanidinium isothiocya-
nate method [16]. RNA was electrophoresed through a 1.2%
agarose gel containing 2.2 M formaldehyde. Equal loading of the
lanes was evaluated by ethidium bromide staining of the 18 and 28
S RNA. The RNA was transferred to nylon membranes (Zet-
abind; Cuno, Meriden, CT, USA) by vacuum blotting and UV
cross-linked. Then the membranes were hybridized with the
following probes: interleukin-1/3, JE/MCP-1 (a 577 bp Eco-R I
fragment) and RANTES (Eco-R 1!XhoI fragment of the murine
RANTES clone pMuR3) after (32P) d CTP-laheling by random
oligonucleotide priming of the eDNA inserts as described earlier
[8, 17, 18]. The eDNA probe for ICAM-1 is a mouse 2.75 kb
EcoRI-fragment, which was obtained from American tissue type
culture collection. Membranes were hybridized with I x 106
cpm/probe per milliliter of hybridization buffer [5 X SSPE, 2 X
Dcnhardt's solution, 150 ig!ml, sonicated and denatured salmon
sperm DNA (Sigma), 0.1% SDS, 5% dextran sulfate, and 50%
formamide] for 18 hours at 42°C. The membranes were washed
twice in 2 x SSC—0.5% SDS (20 x SSC: 3 M sodium chloride—
0.3 M sodium citrate] for 30 minutes at room temperature and
subsequently in 0.4 x SSC—0.5% SDS at 65°C for 30 minutes.
Autoradiography was performed for 2 to 72 hours at —80°C with
intensifying screens. Nylon membranes were stripped for 60
minutes in 5 mivi Tris-HC1 (pH 8.0), 0.5% sodium pyrophosphate,
5 >< Denhardt's, and 0.2 ms EDTA (pH 8.0) at 65°C and
rehybridized with a 0.58 kb EcoRI eDNA probe of human 18 S
RNA to account for small loading and transfer variabilities. To
study the release of chemotactic activity, glomeruli from control
rats, nephritic rats and nephritic rats with anti-MCP-1 antiserum
were isolated 24 hours after antibody as described above. Gb-
meruli from each preparation were counted to assess chemotactic
activity in a equal number of glomeruli. Following isolation the
glomeruli were incubated in serum free RPMI medium for three
hours at 5% C02—95% air at 37°C. Conditioned media were
collected following centrifugation of the glomeruli and were
frozen at —20°C until they were evaluated for their chemotactic
activity. This study was performed in three complete sets.
Immunoblotting of MCP-1
Immunoblotting was performed as described recently by us [19].
RANTES, rat GRO and rat macrophage inflammatory protein 1
alpha (MIP-1 alpha) were purchased fom Pepro Tech (Canton,
MA, USA). For electrophoresis, the proteins were dissolved in
SDS sample buffer containing 10% 2-mercaptoethanol, boiled for
two minutes and separated on 15% polyacrylamide gels. Sepa-
rated proteins were transferred electrophoretically to polyvinyl
membrane. Blocking was performed in 5% non-fat dry milk
prepared in PBS containing 0.1% tween 20 and MCP-1 protein
was identified immunochemically by incubating the membrane
sequentially in rabbit antiserum or non-immune serum (1:250
dilution) and horseradish peroxidase conjugated goat-anti-rabbit
IgG. The signal was developed with luminescence immunodetec-
tion (ECL Western blotting System; Amersham Co., Arlington
Heights, IL, USA).
Monocyte chemotactic activity
Monocyte chemotactic activity was determined in modified
Boyden chambers using freshly prepared human peripheral blood
mononuclear cells [19]. Rat vascular smooth muscle cells (VSMC)
were grown to confluence, rinsed and incubated in serum-free
medium for 48 hours. The vascular smooth muscle cells have been
described recently by us [19]. Medium was collected, clarified by
centrifugation at 10,000 g for two minutes and stored at —20°C
until analyzed. Following a 30 minute incubation at 37°C with or
without a 1:100 dilution of rabbit antibody to MCP-1 samples
were assayed for monocyte chemotactic activity. Blood was drawn
into acid-citrate-dextrose and centrifuged at 550 g for 20 minutes.
The cell pellet was resuspended in HBSS containing 0.27%
dextrose and 0.37% sodium citrate and layered over 1 volume of
histopaque-1077 (Sigma) and centrifuged at 400 g for 40 minutes.
The mononuclear cell layer was washed in HBSS and resuspended
Rantes GAO MIP1 MCP-1
alpha
in RPMI-0.2% albumin to 3.5 >< 10' cells/mi. The monocyte cell
chemotaxis was quantitated on 8 pore polycarbonate filters in
blind-well chambers (Poretics, Livermore, CA, USA). Solutions
of chemoattractants (conditioned media of VSMC or glomeruli)
were diluted with RPMI-0.2% albumin and 200 1d were placed in
the lower compartment of the chambers. Monocytes (500 d,
3.5 X 106 cells/ml) were added to the compartments above the
filters. The chambers were incubated at 37°C for 90 minutes in a
humidified 5% CO2 atmosphere. The filters were removed and
stained with Giemsa and chemotaxis was assayed by counting the
number of cells on the attractant side of the filter in 10 oil-
immersion fields. Chemotactic activity is expressed as the mean
number of monocytes migrating per field in ten high power fields.
Histology
Renal tissue was obtained from control (N = 6) and nephritic
animals (N = 6 each group and time point) for light microscopy
and immunohistologic staining for ED-i and PCNA positive cells.
For this purpose tissues were fixed in 4% buffered formaldehyde
and embedded in paraffin. Formalin fixed tissues were stained
with antibodies to ED-i [20] and anti-proliferating cell nuclear
antigen. (M879; Dakopatts, Hamburg, Germany). The tissue
sections were developed with the APAAP complex using antibod-
ies described earlier [14]. Tissues were double stained with
anti-PCNA and anti-ED-I antibodies. Tissues were also stained
for rabbit lgG and rat C3 using antibodies as described [18].
Polymorphonuclear granulocytes (PMNs) were evaluated in PAS
stained tissues. To evaluate the appearance of PMNs and M/M as
well as proliferating glomerular cells, at least 100 glomeruli (mean
117 7) were evaluated from six different kidneys of each group
and time point. Six control kidneys were assessed in the same
manner. Cell counts are expressed per glomerular cross section.
Fig. 1. Characterization of the antiserum.
Recombinant proteins were fractionated by
SDS-PAGE. After transfer to nitrocellulose, the
blots were incubated with rabbit antiserum to
MCP-1 or non-immune serum and bands were
visualized by luminescence immunodetection as
described in the Methods section. Numbers on
the right represent sizes in kDa. The figures are
representative of two experiments and
demonstrate that the antiserum hinds a single
band. Moreover the antiserum does not cross-
react with other chemokines like RANTES, rat
GRO and rat MTP-l alpha.
Statistical analysis
Results are expressed as means SaM unless stated otherwise.
Statistical significance was defined as P < 0.05. To compare two
distinct treatment groups (that is, nephritic vs. control or nephritic
vs. treated animals), we applied the Mann-Whitney test. For
comparison of all three treatment groups (that is, nephritic/
treated/control) the Kruskal-Wallis ranks test was used. If not
indicated otherwise, results of Mann-Whitney test always corre-
spond to comparison of nephritic versus treated animals.
Results
Characterization of the antiserum
By Western blotting the antiserum generated against MCP-1
reacted specifically against recombinant rat MCP-1 (Fig. 1).
Non-immune serum showed no reactivity (Data not shown).
Moreover, the antiserum did not cross-react with other chemo-
kines like RANTES, rat GRO and rat MIP-1 alpha (Fig. 1).
Rat VSMC secrete monocyte chemotactic activity into the
medium as recently described by us [19]. Following incubation
with the antiserum generated against MCP-1 monocyte chemo-
tactic activity in the medium was inhibited by --66%. Non-
immune serum had no inhibitory effect (Fig. 2).
Northern blot analysis
The Northern blot analysis from control and nephritic glomer-
uli for MCP-I, IL-ID, ICAM-1 and RANTES showed marked
differences (Fig. 3). In glomeruli from control rats mRNA for
MCP-1 was barely detectable, however, it increased markedly at
three hours and 24 hours. The mRNA levels for glomerular
MCP-1 were further elevated when the rats were treated with the
rabbit anti-rat MCP-1 antiserum (Fig. 3). In contrast to MCP-I,
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Fig. 2. Inhibition of monocyte chemotactic activity by MCP-1 antiserum.
Serum-free medium conditioned for 48 hours by rat VSMC (CM) was
incubated with or without a 1:100 dilution of rabbit antiserum to MCP-1
or non-immune rabbit serum (NRS) for 30 minutes at 37°C. The condi-
tioned medium was assayed for monocyte chemotactic activity as de-
scribed in the Methods section. Background migration in response to
nonconditioned medium was 3.4 + 0.3 monocytes/high power field and
was subtracted from all values. Experiments were carried out in duplicates.
The anti-MCP1 antiserum markedly inhibited migration of monocytes.
RANTES mRNA expression in glomeruli was not induced at
three hours and at 24 hours following the antibody. Glomerular
mRNA levels of RANTES were not affected by the rabbit anti-rat
MCP-i antiserum. Similarly, the mRNA expression of IL-1/3 and
ICAM-1, which was increased in the nephritic glomeruli, was not
changed by the antibody treatment. These findings suggest that
the anti-MCP-1 antiserum did not have any overall effect on the
underlying inflammatory mediator stimulus for the generation of
the ATS-induced glomerular injury, but was specific for MCP-l.
Infiltration of MIM and PMIVs into glomeruli
Histologic studies reveal that infiltration of PMNs follows
anti-Thy-i antibody binding to the mesangium (Figs. 4 and 5 and
Table 1). At 24 hours the appearance of M!M is a typical feature
of this lesion (Fig. 6 and Table 1). Treatment of rats with the
anti-MCP-1 antiserum did not affect glomerular accumulation of
PMNs (Table 1), nor did it influence the number of PCNA +
cells. The anti-MCP-1 antiserum, however, significantly reduced
the recruitment of MIM in glomeruli at 24 hours (Table 1). Since
double staining of the tissue for ED1 (+) and PCNA (+) cells was
performed, it was possible to determine the M/M count for
proliferating cells. In all the tissues evaluated, no cell could be
detected that had a double stain. This excludes the possibility that
cells other than M/M accounted for the reduced cell number
following anti-MCP-l antiserum.
1 2 3 4 5
Fig. 3. Northern blot analysis. Compared with glomeruli from control
animals (lane 1), glomeruli of nephritic rats had higher mRNA levels of
MCP-1 at three hours (lane 2) and 24 hours (lane 4). MCP-1 mRNA
expression further increased, when the rats were treated with the anti-
MCP-1 antiserum (3 hr, lane 3; 24 hr, lane 5). Similarly as for MCP-1,
IL-113 mRNA expression also increased in nephritic rats, whereas the
mRNA expression of RANTES remained unaffected. IAM-i mRNA
levels only marginally increased at three hours following the induction of
the nephritis. The anti-MCP-1 antiserum did not affect mRNA expression
of lL-1/3 or ICAM-1.
Chemotactic activity of glomendar supernatants
The chemotactic activity of the conditioned media from ne-
phritic glomeruli was significantly higher when compared with
non-nephritic controls (Fig. 7). This increased chemotactic activ-
ity of nephritic animals was completely blocked in animals that
received the neutralizing anti-MCP-1 antiserum.
Discussion
Leukocyte accumulation in glomeruli and the tubulointersti-
tium is a hallmark of most immune-mediated glomerular injuries.
The recruitment of inflammatory cells is mediated by coordinated
events, which include cell adhesion to the endothelium followed
by migration into the glomerular or tubular interstitium. Studies
in experimental models of glomerulonephritis have shown that
adhesion molecules, such as ICAM-1 and LFA1 play a role in this
0
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Fig. 4. (top left) Following the intravenous injection of the anti-thymocyte-
serum (A TS) and the anti-MCP-1 antiserum selective binding of rabbit IgG
was detected in the mesangium by immunohistology (red stain). This was not
different from rats which received ATS and non-immune serum and
demonstrates that ATS binding was unaffected. Similarly, staining for rat
C3 was not different from rats that received ATS or non-immune serum
(not shown).
Fig. 5. (top right) At three hours fbllowing the injection of the antisera
infiltration of polymoiphonuclear granulocytes can be detected in glomendi(arrows). This infiltration of PMNs was not affected by the anti-MCP-1
antiserum (Table 1).
Fig. 6. (left) At 24 hours glomeruli showed infiltration of monocytesi
macrophages (brown) and the appearance of PCNA (+) cells (red). The
infiltration of monocytes/macrophages was reduced when the animals
were treated with anti-MCP-1 antiserum (Table 1).
Reproduction of Figures 4, 5 and 6 in color was made possible by a grant
from Baxter Healthcare Corporation, MeGaw Park, Illinois.
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Table 1. Histologic studies
Nephritis + Nephritis +
Nephritis anti-MCP-1 Nephritis anti-MCP-1
Control (3 hrs) (3 hrs) (24 hrs) (24 hrs)(N=6) (N=6) (N=6) (N=6) (N=6)
ED-i (+) cells 0.09 0.04 0.32 0.06a 0.25 O.O3' 2.79 0.3Y' 1.70 OlSah
Polymorphonuclear cells
PCNA (+) cells
0
0.52 0.04
1.44 0.41a
0.50 0.08
1.08 0.27
1.00 0.14"
0.21 0.13
1.39 0.35
0.08 0.04
1.70 0.3Y
a p < 0.02 versus Control
h P < 0.02 versus Nephritis
Control Nephritis Nephritis
+Anti
MCP-1
Fig. 7. Chemotactic activity of glomerular supernatants. Glomeruli were
isolated from normal, nephritic and nephritic rats treated with anti MCP-i
antiserum 24 hours after disease induction. Conditioned medium was
assayed for chemotactic activity. Chemotactic activity of the nephritic rats
was higher when compared with non-nephritic controls. This increased
activity was not present in glomeruli isolated from nephritic rats which
received the anti MCP-1 antiserum. The Figure is a representative of two
separate experiments.
process [211, as well as lipid mediators and members of the
-C-X-C- family of the chemokines [22—24]. These studies have
focused on the recruitment of polymorphonuclear granulocytes
and could convincingly demonstrate a role for -C-X-C- chemo-
kines in the adhesion and migration of PMNs in glomcrulonephri-
tis.
No direct evidence, however, is available as to how the recruit-
ment of M/M is mediated in anti-Thy-i glomerulonephritis.
Among the chemokines members of the -C-C- group, MCP-i and
RANTES have strong chemoattractant activities [25, 26] for
monocytes. Studies in cell cultures and animal models strongly
suggest that these members of the chemokine family are involved
in MIM recruitment [9, 14, 271. However, in vivo intervention
studies for -C-C- chemokines with neutralizing antibodies in the
anti-Thy I glomerulonephritis are lacking.
The present study provides direct evidence that the chemokine
MCP-i contributes to the accumulation of M/M in the glomeruli
of rats with ATS-induced glomerulonephritis. The presence of
MCP-1 was demonstrated by increased mRNA levels and chemo-
tactic activity in nephritic glomeruli. The administration of anti-
MCP-1 antibody shortly after the induction of nephritis reduced
the accumulation of M/M at 24 hours by about 40%. This partial
inhibition is vesy similar to the inhibition of PMN influx in rats
with anti-GBM nephritis after injection of neutralizing antibodies
against the -C-X-C- chemokines CINC and MIP-2 [23, 24], and
data in a recent paper with an antibody against MCP-1 [281. These
findings suggest that in different models of glomerulonephritis
more than one chemoattractant is responsible for the infiltration
of leukocytes. The antibody treatment did not affect recruitment
of PMNs confirming the selectivity of the antibody. The reduction
of M/M accumulation in glomeruli was also associated with a
decrease in the chemotactic activity of conditioned medium
isolated from riephritic glomeruli of rats, which were treated with
the anti-MCP-1 antiserum. Whereas the recruitment of M/M and
the chemotactic activity was reduced, glomerular mRNA levels of
MCP-1 increased in these animals that received the anti-MCP-i
antiserum. The mechanism of this increase in MCP-1 mRNA
expression is unclear. However, it is possible that the anti-MCP-1
antiserum inhibits a positive feedback loop of MCP-1 in the
nephritic glomeruli. It is unlikely that this increased MCP-1
mRNA expression is due to the effect of other inflammatory
mediators, known to stimulate MCP-1 formation, such as IL-1f3,
since its expression remained unchanged in the nephritic animals
that received the anti-MCP-i antiserum. Therefore, the effects of
the anti-MCP-1 antiserum is most likely related to the selective
role of MCP-1 on monocytes in this lesion. The infusion of
anti-MCP-1 antiserum, however, did not completely block the
accumulation of monocytes, indicating that other factors are
required for M/M accumulation. Monoclonal antibodies to
ICAM-1 or to the CD18 subunit of the CD11/CD18 integrins
inhibit C5a- and LTB4-induced adhesion of monocytes to mesan-
gial cells [29]. Since ICAM-1 mRNA expression is mildly in-
creased in nephritic glomeruli, ICAM-1 in addition to MCP-1 may
participate in monocyte recruitment to the glomerulus.
In summary, these studies demonstrate that MCP-1 is an
important mediator of monocyte-recruitment in the anti-thymo-
cyte antibody induced glomerular injury. MCP-1 together with
other chemoattractants and inflammatory mediators participate in
the activation and the accumulation of monocytes in glomerulo-
nephritis.
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Appendix
Ahbrevations are: ICAM-1, intercellular adhesion molecule-i; IL-iD,
interleukin-113; RANTES, regulated on activation, normal T cell ex-
pressed and secreted; MCP-1, monocyte chemoattractant protein-I; M/M,
monocytes/macrophages; VSMC, vascular smooth muscle cells; PMN,
polymorphonuclear granulocytes; ATS, anti-rat-thymocyte antiserum;
PCNA, proliferating cell nuclear antigen.
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